BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17880618)

  • 21. A case study of a child with chronic hemolytic anemia due to a Donath-Landsteiner positive, IgM anti-I autoantibody.
    Karafin MS; Shirey RS; Ness PM; King KE; Keefer J
    Pediatr Blood Cancer; 2012 Nov; 59(5):953-5. PubMed ID: 22553072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two case studies and a review of paroxysmal cold hemoglobinuria.
    Slemp SN; Davisson SM; Slayten J; Cipkala DA; Waxman DA
    Lab Med; 2014; 45(3):253-8; quiz e92. PubMed ID: 25051079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
    Peñalver FJ; Alvarez-Larrán A; Díez-Martin JL; Gallur L; Jarque I; Caballero D; Díaz-Mediavilla J; Bustelos R; Fernández-Aceñero MJ; Cabrera JR;
    Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of refractory neuroSjogren with Rituximab.
    Yamout B; El-Hajj T; Barada W; Uthman I
    Lupus; 2007; 16(7):521-3. PubMed ID: 17670852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of paroxysmal cold hemoglobinuria in a boy after physical cooling for fever.
    Mantadakis E; Bezirgiannidou Z; Martinis G; Chatzimichael A
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):40-2. PubMed ID: 21063222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
    Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
    Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
    Reguiaï Z; Tchen T; Perceau G; Bernard P
    Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
    Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
    J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies.
    Webster D; Ritchie B; Mant MJ
    Am J Hematol; 2004 Apr; 75(4):258-9. PubMed ID: 15054824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
    Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment.
    Connelly EA; Aber C; Kleiner G; Nousari C; Charles C; Schachner LA
    Pediatr Dermatol; 2007; 24(2):172-6. PubMed ID: 17461818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.
    Kieu V; O'Brien T; Yap LM; Baker C; Foley P; Mason G; Prince HM; McCormack C
    Australas J Dermatol; 2009 Aug; 50(3):202-6. PubMed ID: 19659984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
    Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosis.
    Breccia M; D'Elia GM; Girelli G; Vaglio S; Gentilini F; Chiara S; Alimena G
    Eur J Haematol; 2004 Oct; 73(4):304-6. PubMed ID: 15347319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report.
    Prince SD; Winestone LE; Nance SJ; Friedman DF
    Transfusion; 2017 Jun; 57(6):1401-1406. PubMed ID: 28369934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy.
    Ahn ER; Lander G; Bidot CJ; Jy W; Ahn YS
    Am J Hematol; 2005 Feb; 78(2):127-9. PubMed ID: 15682409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.